New Mexico Cancer Center - Albuquerque

Albuquerque, New Mexico 87109

0 studies enrolling now · 2 studies all time

What they study most

Cancer, Metastatic Hormone-sensitive Prostate Cancer

Studies at this site

• Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer — Running, not enrolling
• A Study to Learn How Well Darolutamide Administered Together With Androgen Deprivation Therapy (ADT) Works in Men With Metastatic Hormone-sensitive Prostate Cancer. Results Will be Compared With ADT Alone From a Previously Conducted Study. — Running, not enrolling